A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants

Stopped The justification of the early termination of the trial: the study is early terminated due to the Coronavirus 2019 epidemic.

Conditions

• Healthy

Interventions

• DRUG: ALXN1830
• DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.